Summary
The liver is actively involved in the metabolism of the sulphur-containing essential amino acid, methionine. Methionine is transformed into S-adenosyl-L-methionine (SAMe) and then into sulphur-containing metabolites (cysteine, taurine and glutathione) via the trans-sulphuration pathway. Liver disease may affect the trans-sulphuration pathway and decrease the clearance of methionine, which leads to increased fasting methionine concentrations in blood and reduced formation of cysteine and glutathione. There is evidence that this defect, located at the level of SAMe-synthetase, may cause nutritional defects and contribute to negative nitrogen balance whenever non-essential sulphur-containing amino acids are not supplied in adequate amounts. In addition, cirrhotic patients may be at increased risk of hepatotoxicity after treatment with substances which are detoxified via glutathione. The SAMe-synthetase block may be overcome by administration of oral or intravenous SAMe, which improves the fasting amino acid profile and increases the hepatic glutathione concentration. Controlled studies on long term SAMe treatment in patients with cirrhosis are needed to confirm this possible beneficial effect.
Similar content being viewed by others
References
Bell KM, Plon L, Bunney WE, Potkin SG. S-adenosylmethionine treatment of depression: a controlled clinical trial. American Journal of Psychiatry 145: 1110–1114, 1988
Bremer J, Greenberg DM. Methyl transferring enzyme system of microsomes in the biosynthesis of lecithin (phosphatidylcholine). Biochimica et Biophysica Acta 46: 205–216, 1961
Burgunder J-M, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis. European Journal of Clinical Investigation 17: 408–414, 1987
Cabrero C, Puerta J, Alemany S. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. European Journal of Biochemistry 170: 299–304, 1987
Cabrero C, Duce AM, Ortiz P, Alemany S, Mato JM. Specific loss of the high molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology 8: 1530–1534, 1988
Cascino A, Cangiano C, Calcaterra V, Rossi Fanelli P, Capocaccia L. Plasma amino acid imbalance in patients with liver disease. Digestive Diseases 23: 591–598, 1978
Duce AM, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8: 65–68, 1988
Gahl WA, Bernardini I, Finkelstein JD, Tangerman A, Martin JJ, et al. Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. Journal of Clinical Investigation 81: 390–397, 1988
Gaull GE, Rassin DK, Solomon GE. Biochemical observations on so-called hereditary tyrosinemia. Pediatric Research 4: 337–344, 1970
Giulidori P, Galli-Kienle M, Catto E, Stramentinoli G. Transmethylation, transsulfuration and aminopropylation reactions of S-adenosyl-L-methionine in vivo. Journal of Biological Chemistry 259: 4205–4211, 1984
Harper HA, Kinsell LW, Barton HC. Plasma L-methionine levels following intravenous administration in humans. Science 106: 319–320, 1947
Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. S-adenosylmethionine and S-adenosylhomocysteine metabolism in isolated rat liver. Journal of Biological Chemistry 255: 10822–10827, 1980
Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 81: 668–675, 1981
Jewell SA, Di Monte D, Gentile A, Guglielmi A, Altomare E, et al. Decreased hepatic glutathione in chronic alcoholic patients. Journal of Hepatology 3: 1–6, 1986
Kinsell LW, Harper HA, Barton HC, Michaels GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 106: 589–590, 1947
Kinsell LW, Harper HA, Barton HC, Hutchin ME, Hess JR. Studies in methionine and sulfur metabolism. I. The fate of intravenously administered methionine, in normal individuals and in patients with liver damage. Journal of Clinical Investigation 27: 667–689, 1948
Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatoxicity. Gut 29: 1153–1157, 1988
Lauterburg BH, Velez ME, Mitchell JR. Plasma glutathione (GSH) as an index of intrahepatic GSH in man: response to acetaminophen and chronic ethanol abuse. Hepatology 4: 1051 (A 180), 1984
Lieber CS, Casini A, De Carli LM, Kim C, Lowe N, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165–172, 1990
Marchesini G, Bianchi GP, Vilstrup H, Checchia GA, Patrono D, et al. Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. Journal of Hepatology 4: 108–117, 1987
Marchesini G, Bianchi GP, Lolli R, Zoli M, Pisi E. Effect of S-adenosylmethionine (SAMe) on plasma levels of sulfur-containing amino acids (SCAA) in patients with liver cirrhosis. Journal of Hepatology 7: S148, 1988
Marchesini G, Almasio P, Luca A, Maggioni Moratti E, Pisi E, et al. Sulfur amino acid (SAA) pattern in compensated chronic liver diseases. European Journal of Clinical Investigations 19: A94, 1989
Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Paracetamol-induced hepatic necrosis. IV. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 187: 211–217, 1973
Morgan M. Alcohol and nutrition. British Medical Bulletin 38: 21–29, 1982
Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino acid patterns in liver disease. Gut 23: 362–370, 1982
Pezzoli C, Stramentinoli G, Galli-Kienle M, Plaff E. Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes. Biochemical and Biophysical Research Communications 85: 1031–1038, 1978
Poulsen HE, Ranek L, Andreasen PB. The hepatic glutathione content in liver disease. Scandinavian Journal of Clinical and Laboratory Investigations 41: 573–576, 1981
Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma aminoacid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72: 483–487, 1977
Rudman D, Kutner M, Ansley J, Jansen R, Chipponi J, et al. Hypotyrosinemia, hypocistinemia, and failure to retain nitrogen during total parenteral nutrition of cirrhotic patients. Gastroenterology 81: 1025–1035, 1981
Silk DBA. Parenteral nutrition in patients with liver disease. Journal of Hepatology 7: 269–277, 1988
Stegink LD, Besten LD. Synthesis of cysteine from methionine in normal adult subjects: effect of route of alimentation. Science 178: 514–516, 1972
Stramentinoli G. Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. American Journal of Medicine 83: 35–42, 1987
Vendemiale G, Altomare E, Trizio T, LeGrazie C, Di Padova C, et al. Effects of S-adenosyl-L-methionine on hepatic glutathione in patients with liver injury. Scandinavian Journal of Gastroenterology 24: 407–415, 1989
Vilstrup H, Bucher D, Krog B, Damgård SE. Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. European Journal of Clinical Investigation 12: 197–202, 1982
Zeisel SH, Poole JR. Dietary intake of methionine: influence on brain S-adenosylmethionine. In Usdin et al. (Eds) Transmethylation, pp. 59–68, Elsevier/North-Holland, The Netherlands, 1979
Zieve L, Doizaki WM, Zieve FJ. Synergism between mercaptans and dimethylsulfide in liver cirrhosis before and after ingestion of methionine. Journal of Laboratory and Clinical Medicine 74: 861, 1969
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pisi, E., Marchesini, G. Mechanisms and Consequences of the Impaired Trans-Sulphuration Pathway in Liver Disease: Part II. Drugs 40 (Suppl 3), 65–72 (1990). https://doi.org/10.2165/00003495-199000403-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000403-00007